BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8944309)

  • 1. Does tuberin function as a tumor suppressor in the cerebral lesions of tuberous sclerosis? Early observations.
    Short MP
    Brain Pathol; 1996 Oct; 6(4):375-6. PubMed ID: 8944309
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberous sclerosis and tuberin: what do we learn from in situ localization data in the human brain?
    Wiestler OD; Wolf HK
    Brain Pathol; 1996 Oct; 6(4):376-7. PubMed ID: 8944310
    [No Abstract]   [Full Text] [Related]  

  • 3. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberous sclerosis complex: genetics to pathogenesis.
    Narayanan V
    Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis-related gene expression in normal and dysplastic brain.
    Vinters HV; Kerfoot C; Catania M; Emelin JK; Roper SN; DeClue JE
    Epilepsy Res; 1998 Sep; 32(1-2):12-23. PubMed ID: 9761305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
    Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG
    Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma.
    Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S
    Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
    Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE
    J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse homologue of the tuberin gene (TSC2) maps to a conserved synteny group between mouse chromosome 17 and human 16p13.3.
    Olsson PG; Sutherland HF; Nowicka U; Korn B; Poustka A; Frischauf AM
    Genomics; 1995 Jan; 25(1):339-40. PubMed ID: 7774953
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of the protein truncation test (PTT) for the detection of tuberculosis sclerosis complex type 1 and 2 (TSC1 and TSC2) mutations.
    Mayer K
    Methods Mol Biol; 2003; 217():329-44. PubMed ID: 12491945
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.
    Wolf HK; Normann S; Green AJ; von Bakel I; Blümcke I; Pietsch T; Wiestler OD; von Deimling A
    Acta Neuropathol; 1997 Jan; 93(1):93-6. PubMed ID: 9006662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
    Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
    Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR
    Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
    Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberin loss from cerebral tissues.
    Vinters HV; Kerfoot C; Emelin JK
    Ann Neurol; 1997 Aug; 42(2):270-2. PubMed ID: 9266743
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular genetic advances in tuberous sclerosis.
    Cheadle JP; Reeve MP; Sampson JR; Kwiatkowski DJ
    Hum Genet; 2000 Aug; 107(2):97-114. PubMed ID: 11030407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity.
    Wienecke R; König A; DeClue JE
    J Biol Chem; 1995 Jul; 270(27):16409-14. PubMed ID: 7608212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.
    Nellist M; Goedbloed MA; Halley DJ
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):587-91. PubMed ID: 12773161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TSC2/PKD1 contiguous gene syndrome.
    Harris PC
    Contrib Nephrol; 1997; 122():76-82. PubMed ID: 9399043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.